A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder
Public ClinicalTrials.gov record NCT02045862. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Multi-center Study to Evaluate the Long-Term Safety and Efficacy of Combination of Solifenacin Succinate With Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in Subjects With Overactive Bladder
Study identification
- NCT ID
- NCT02045862
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Astellas Pharma Europe B.V.
- Industry
- Enrollment
- 1,829 participants
Conditions and interventions
Conditions
Interventions
- Mirabegron Drug
- Placebo to match mirabegron Drug
- Placebo to match solifenacin Drug
- Solifenacin succinate Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 16, 2014
- Primary completion
- Sep 7, 2016
- Completion
- Sep 7, 2016
- Last update posted
- Oct 30, 2024
2014 – 2016
United States locations
- U.S. sites
- 75
- U.S. states
- 25
- U.S. cities
- 64
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site US10049 | Mobile | Alabama | 36608 | — |
| Site US10112 | Mobile | Alabama | 36608 | — |
| Site US10104 | Chandler | Arizona | 85224 | — |
| Site US10021 | Phoenix | Arizona | 85051 | — |
| Site US10122 | Anaheim | California | 92801 | — |
| Site US10082 | Hawaiian Gardens | California | 90716 | — |
| Site US10132 | Los Angeles | California | 90017 | — |
| Site US10133 | Los Angeles | California | 90036 | — |
| Site US10149 | Paramount | California | 90723 | — |
| Site US10003 | San Diego | California | 92120 | — |
| Site US10106 | Tarzana | California | 91356 | — |
| Site US10595 | Valley Village | California | 91607 | — |
| Site US10053 | Wheat Ridge | Colorado | 80033 | — |
| Site US10060 | Bradenton | Florida | 34208 | — |
| Site US10097 | Hialeah | Florida | 33012 | — |
| Site US10148 | Hialeah | Florida | 33016 | — |
| Site US10153 | Hialeah | Florida | 33016 | — |
| Site US10091 | Jupiter | Florida | 33458 | — |
| Site US10150 | New Port Richey | Florida | 34652 | — |
| Site US10124 | Orlando | Florida | 32803 | — |
| Site US10134 | Orlando | Florida | 32806 | — |
| Site US10009 | Pembroke Pines | Florida | 33027 | — |
| Site US10554 | Plantation | Florida | 33317 | — |
| Site US10037 | Alpharetta | Georgia | 30005 | — |
| Site US10127 | Roswell | Georgia | 30076 | — |
| Site US10120 | Sandy Springs | Georgia | 30328 | — |
| Site US10078 | Wichita | Kansas | 67205 | — |
| Site US10088 | Lake Charles | Louisiana | 70601 | — |
| Site US10025 | Shreveport | Louisiana | 71106 | — |
| Site US10558 | Hanover | Maryland | 21076 | — |
| Site US10282 | Boston | Massachusetts | 02131 | — |
| Site US10114 | Watertown | Massachusetts | 02472 | — |
| Site US10110 | Billings | Montana | 59102 | — |
| Site US10154 | Missoula | Montana | 59801 | — |
| Site US10553 | Lincoln | Nebraska | 68510 | — |
| Site US10002 | Englewood | New Jersey | 07631 | — |
| Site US10047 | Lawrenceville | New Jersey | 08648 | — |
| Site US10011 | Albuquerque | New Mexico | 87102 | — |
| Site US10015 | Albuquerque | New Mexico | 87109 | — |
| Site US10026 | Garden City | New York | 11530 | — |
| Site US10040 | Kingston | New York | 12401 | — |
| Site US10168 | New York | New York | 10065 | — |
| Site US10126 | Newburgh | New York | 12550 | — |
| Site US10028 | Poughkeepsie | New York | 12601 | — |
| Site US10076 | Concord | North Carolina | 28025 | — |
| Site US10129 | Raleigh | North Carolina | 27609 | — |
| Site US10062 | Winston-Salem | North Carolina | 27103 | — |
| Site US10050 | Cleveland | Ohio | 44122 | — |
| Site US10067 | Wadsworth | Ohio | 44281 | — |
| Site US10109 | Oklahoma City | Oklahoma | 73112 | — |
| Site US10541 | Medford | Oregon | 97504 | — |
| Site US10008 | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Site US10017 | Philadelphia | Pennsylvania | 19114 | — |
| Site US10167 | Pittsburgh | Pennsylvania | 15213 | — |
| Site US10250 | Pittsburgh | Pennsylvania | 15236 | — |
| Site US10248 | Pittsburgh | Pennsylvania | 15243 | — |
| Site US10063 | Uniontown | Pennsylvania | 15401 | — |
| Site US10012 | West Reading | Pennsylvania | 19611 | — |
| Site US10166 | Charleston | South Carolina | 29425 | — |
| Site US10079 | Mt. Pleasant | South Carolina | 29464 | — |
| Site US10023 | Simpsonville | South Carolina | 29681 | — |
| Site US10101 | Summerville | South Carolina | 29485 | — |
| Site US10006 | Kingsport | Tennessee | 37660 | — |
| Site US10065 | Corpus Christi | Texas | 78414 | — |
| Site US10085 | Houston | Texas | 77058 | — |
| Site US10219 | Houston | Texas | 77094 | — |
| Site US10093 | Houston | Texas | 77099 | — |
| Site US10090 | Hurst | Texas | 76054 | — |
| Site US10105 | San Antonio | Texas | 78229 | — |
| Site US10111 | San Antonio | Texas | 78229 | — |
| Site US10083 | Virginia Beach | Virginia | 23462 | — |
| Site US10013 | Burien | Washington | 98166 | — |
| Site US10004 | Mountlake Terrace | Washington | 98043 | — |
| Site US10155 | Seattle | Washington | 98105 | — |
| Site US10135 | Walla Walla | Washington | 99362 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 176 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02045862, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 30, 2024 · Synced May 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02045862 live on ClinicalTrials.gov.